Help | RSS Feed

Acerus Pharmaceuticals Corp. (TSE:ASP.TO) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Acerus Pharmaceuticals Corp. (TSE:ASP.TO) seasonal charts above shows that a Buy Date of December 20 and a Sell Date of April 18 has resulted in a geometric average return of 16.39% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 51.01% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company. Principally, it is engaged in the development, manufacture, marketing, and distribution of branded products in men’s and women’s health. The company markets its product under brand ESTRACE, NATESTO, GYNOFLOR and TEFINA. The ESTRACE brand markets in Canada and is for the symptomatic relief of menopausal symptoms. Its NATESTO is a licensed nasal gel technology for replacement therapy in adult males diagnosed with hypogonadism. GYNOFLOR offers ultra-low dose vaginal estrogen therapy. Its TEFINA brand product is a low-dose nasal testosterone gel treatment in development for female sexual dysfunction.

To download ASP.TO seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z